Endothelin A receptor

From WikiMD's WELLNESSPEDIA

Endothelin A receptor (ETA receptor) is a type of endothelin receptor that has a high affinity for endothelin-1. It is a G protein-coupled receptor (GPCR) that is primarily found in the vascular smooth muscle where it plays a role in vasoconstriction and cell proliferation.

Structure[edit]

The ETA receptor is a 427-amino acid protein that belongs to the GPCR family. It has seven transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus. The receptor's structure allows it to bind to endothelin-1 and initiate a cascade of intracellular events.

Function[edit]

The primary function of the ETA receptor is to mediate the effects of endothelin-1, a potent vasoconstrictor. When endothelin-1 binds to the ETA receptor, it activates the G protein, which in turn activates a series of intracellular signaling pathways. These pathways lead to the contraction of vascular smooth muscle cells, resulting in vasoconstriction.

In addition to its role in vasoconstriction, the ETA receptor also plays a role in cell proliferation. It has been found to be overexpressed in several types of cancer, including ovarian cancer, prostate cancer, and melanoma.

Clinical significance[edit]

Due to its role in vasoconstriction and cell proliferation, the ETA receptor is a potential target for the treatment of various cardiovascular and cancerous diseases. Several ETA receptor antagonists have been developed and are currently in clinical trials.

See also[edit]

References[edit]



This GPCR-related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.